Should hepatitis B vaccine be used for infants?

References

• Goldstein ST, Zhou F, Hadler SC et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int. J. Epidemiol.34(6), 1329–1339 (2005).
   PubMed Web of Science ®Google Scholar
• World Health Organization. Hepatitis B vaccines. WHO position paper. Wkly Epidemiol. Rec.79(28), 255–263 (2004).
   PubMedGoogle Scholar
• Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer61, 1942–1956 (1988).
   PubMed Web of Science ®Google Scholar
• Hsieh CC, Tzonou A, Zavitsanos X, Kaklamani E, Lan SJ, Trichopoulos D. Age at first establishment of chronic hepatitis B virus infection and hepatocellular carcinoma risk. A birth order study. Am. J. Epidemiol.136, 1115–1121 (1992).
   PubMed Web of Science ®Google Scholar
• Shibuya K, Mathers CD, Boschi-Pinto C, Lopez AD, Murray CJ. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer2, 37 (2002).
   PubMed Web of Science ®Google Scholar
• Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann. NY Acad. Sci.963, 13–20 (2002).
   PubMed Web of Science ®Google Scholar
• Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol.45(4), 529–538 (2006).
   PubMed Web of Science ®Google Scholar
• Blumberg BS. Australia antigen and the biology of hepatitis B. Nature197, 17–24 (1997).
   Google Scholar
• West DJ, Calandra GB, Hesley TM, Ioli V, Miller WJ. Control of hepatitis B through routine immunization of infants: the need for flexible schedules and new combination vaccine formulations. Vaccine11(Suppl. 1), S21–S27 (1993).
   Google Scholar
• Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med.336, 1855−1859 (1997).
   PubMed Web of Science ®Google Scholar
• Goh KT. Prevention and control of hepatitis B virus infection in Singapore. Ann. Acad. Med. Singapore26, 671–681 (1997).
   PubMedGoogle Scholar
• DeStefano F, Verstraeten T, Chen RT. Hepatitis B vaccine and risk of multiple sclerosis. Expert Rev. Vaccines1(4), 461–466 (2002).
   PubMedGoogle Scholar
• Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J. Med. Virol.44(2), 144–151 (1994).
   PubMed Web of Science ®Google Scholar
• Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. Br. Med. J.332(7537), 328–336 (2006).
   PubMed Web of Science ®Google Scholar
• European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet355, 561–565 (2000).
   PubMed Web of Science ®Google Scholar
• Fitzsimons D, Francois G, Hall A et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine.23(32), 4158–4166 (2005).
   PubMed Web of Science ®Google Scholar
• Cutts FT, Hall AJ. Vaccines for neonatal viral infections: hepatitis B vaccine. Expert Rev. Vaccines3(4), 349–352 (2004).
   PubMedGoogle Scholar
• Edmunds WJ, Medley GF, Nokes DJ et al. The influence of age on the development of the hepatitis B carrier state. Proc. R. Soc. Lond. B. Biol. Sci.253, 197–201 (1993).
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Alward WL, Hall DB et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis.151, 599−603 (1985).
   PubMed Web of Science ®Google Scholar
• Aggarwal R, Ranjan P. Preventing and treating hepatitis B infection. Br. Med. J.329(7474), 1080–1086 (2004).
   PubMedGoogle Scholar
• WHO. Meeting on hepatitis B control through immunization. Tokyo, Japan, 26–28 June, 2002.
   Google Scholar
• Anonymous. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR40(RR-13), 1–25 (1991).
   PubMedGoogle Scholar
• Gilca V, Duval B, Boulianne N, Dion R, De Serres G. Impact of the Quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program. Pediatr. Infect. Dis J.25(4), 372–374 (2006).
   PubMed Web of Science ®Google Scholar
• Miller MA, McCann L. Policy analysis of the use of hepatitis B, Haemophilus influenzae type b-, Streptococcus pneumoniae-conjugate and rotavirus vaccines in national immunization schedules. Health Econ.9(1), 19–35 (2000).
   PubMed Web of Science ®Google Scholar
• Gregson AL, Edelman R. Does antigenic overload exist? The role of multiple immunizations in infants. Immunol. Allergy Clin. North Am.23(4), 649–664 (2003).
   PubMedGoogle Scholar
• Offit PA, Quarles J, Gerber MA et al. Addressing parents’ concerns: do multiple vaccines overwhelm or weaken the infant’s immune system? Pediatrics109(1), 124–129 (2002).
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics, Public Health Service. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service. MMWR48, 563–565 (1999).
   Google Scholar
• Parker SK, Schwartz B, Todd J, Pickering LK. Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics114(3), 793–804 (2004).
   PubMed Web of Science ®Google Scholar
• Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations. Pediatrics118(1), e139–e150 (2006).
   Web of Science ®Google Scholar
• Expanded Programme on Immunization. Global Advisory Group – Part I. Wkly Epidemiol. Rec.67, 11–15 (1992).
   PubMedGoogle Scholar